BlueLinx (BXC) had the highest return between January 20, 2018 and April 21, 2018 by a small-cap US stock, returning 216.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
BlueLinx (BXC) | 1/20/2018 - 4/21/2018 | 216.54% |
Tandem Diabetes Care (TNDM) | 1/20/2018 - 4/21/2018 | 152.2% |
Acm Research (ACMR) | 1/20/2018 - 4/21/2018 | 136.81% |
POET Technologies (POET) | 1/20/2018 - 4/21/2018 | 94.44% |
Geron (GERN) | 1/20/2018 - 4/21/2018 | 94.36% |
DiaMedica Therapeutics (DMAC) | 1/20/2018 - 4/21/2018 | 90.82% |
Vericel Corp Ord (VCEL) | 1/20/2018 - 4/21/2018 | 74.81% |
Uniqure (QURE) | 1/20/2018 - 4/21/2018 | 74.49% |
American Public Education (APEI) | 1/20/2018 - 4/21/2018 | 61.55% |
SolarEdge Technologies (SEDG) | 1/20/2018 - 4/21/2018 | 58.85% |
Eyepoint Pharmaceuticals (EYPT) | 1/20/2018 - 4/21/2018 | 54.46% |
Transcontinental Realty Investors (TCI) | 1/20/2018 - 4/21/2018 | 49.4% |
CareDx (CDNA) | 1/20/2018 - 4/21/2018 | 46.03% |
Know Labs (KNW) | 1/20/2018 - 4/21/2018 | 45.41% |
Regenxbio (RGNX) | 1/20/2018 - 4/21/2018 | 43.66% |
GeoPark (GPRK) | 1/20/2018 - 4/21/2018 | 43.34% |
OFG Bancorp (OFG) | 1/20/2018 - 4/21/2018 | 43.12% |
Axogen (AXGN) | 1/20/2018 - 4/21/2018 | 42.35% |
Abeona Therapeutics (ABEO) | 1/20/2018 - 4/21/2018 | 42.18% |
Herbalife Nutrition (HLF) | 1/20/2018 - 4/21/2018 | 41.83% |
Xpel (XPEL) | 1/20/2018 - 4/21/2018 | 41.61% |
Dine Brands Global (DIN) | 1/20/2018 - 4/21/2018 | 41.55% |
Gyre Therapeutics (GYRE) | 1/20/2018 - 4/21/2018 | 40.75% |
Nutex Health (NUTX) | 1/20/2018 - 4/21/2018 | 40.48% |
Harrow Health (HROW) | 1/20/2018 - 4/21/2018 | 40% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
